<http://schema.org/description>
"Summit Therapeutics (SMMT) gained Rare Pediatric Disease status from the FDA for its experimental Duchenne muscular dystrophy candidate, ezutromid."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/232904/summit-smmt-rare-pediatric-disease-status-for-dmd-drug>